CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics Max Pain By Strike
CRSP trades at $59.72, pinned near the near-term max pain of $59 expiring Aug 15, 2025 (0 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($35-$70), reflecting growing call interest at higher strikes. Key magnetic zone at 48 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
CRISPR Therapeutics Max Pain By Expiry
Max pain for CRSP shows an upward trend from 35 to 70, suggesting bullish positioning in longer-dated options. The 67% spread signals divergent expectations across timeframes. Most levels below 59.72 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 59 | -0.72 (-1.21%) |
| Aug 22, 2025 | 57 | -2.72 (-4.55%) |
| Aug 29, 2025 | 58 | -1.72 (-2.88%) |
| Sep 5, 2025 | 56 | -3.72 (-6.23%) |
| Sep 12, 2025 | 56 | -3.72 (-6.23%) |
| Sep 19, 2025 | 57.5 | -2.22 (-3.72%) |
| Sep 26, 2025 | 50 | -9.72 (-16.28%) |
| Oct 17, 2025 | 47.5 | -12.22 (-20.46%) |
| Dec 19, 2025 | 70 | 10.28 (17.21%) |
| Jan 16, 2026 | 47.5 | -12.22 (-20.46%) |
| Apr 17, 2026 | 35 | -24.72 (-41.39%) |
| Jun 18, 2026 | 45 | -14.72 (-24.65%) |
| Sep 18, 2026 | 50 | -9.72 (-16.28%) |
| Jan 15, 2027 | 40 | -19.72 (-33.02%) |